Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Moodys
Express Scripts
Boehringer Ingelheim
Harvard Business School

Last Updated: January 27, 2023

Heparin sodium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for heparin sodium and what is the scope of freedom to operate?

Heparin sodium is the generic ingredient in thirty-eight branded drugs marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, Solopak, Abraxis Pharm, Akorn, B Braun Medical Inc, Be Pharms, Casi Pharms Inc, Chamberlin Parenterl, Dell Labs, Dr Reddys, Fresenius Kabi Usa, Gland, Hikma, Hospira Inc, Lilly, Mylan Labs Ltd, Nanjing King-friend, Organon Usa Inc, Pfizer, Pharm Spec, Pharmacia And Upjohn, Sagent Pharms, Sandoz, Shenzhen Techdow, Watson Labs Inc, Baxter Hlthcare, Mcgaw, B Braun, Pharma Serve Ny, and 3M, and is included in eighty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-nine drug master file entries for heparin sodium. Twenty-two suppliers are listed for this compound.

Summary for heparin sodium
Drug Prices for heparin sodium

See drug prices for heparin sodium

Recent Clinical Trials for heparin sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
First Affiliated Hospital Xi'an Jiaotong UniversityN/A
Haisco Pharmaceutical Group Co., Ltd.Phase 2
St George Hospital, AustraliaPhase 2/Phase 3

See all heparin sodium clinical trials

Pharmacology for heparin sodium

US Patents and Regulatory Information for heparin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 018916-009 Jan 31, 1984 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Akorn HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 017486-005 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Baxter Hlthcare SODIUM HEPARIN heparin sodium INJECTABLE;INJECTION 017036-001 Mar 4, 1988 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
McKinsey
Medtronic
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.